125 related articles for article (PubMed ID: 23241526)
21. Factors affecting survival of patients with oesophageal cancer: a study using inverse Gaussian frailty models.
Ghadimi MR; Mahmoodi M; Mohammad K; Rasouli M; Zeraati H; Fotouhi A
Singapore Med J; 2012 May; 53(5):336-43. PubMed ID: 22584975
[TBL] [Abstract][Full Text] [Related]
22. Sentinel lymph node biopsy alone has no adverse impact on the survival of patients with breast cancer.
Takei H; Suemasu K; Kurosumi M; Horii Y; Ninomiya J; Yoshida M; Hagiwara Y; Inoue K; Tabei T
Breast J; 2006; 12(5 Suppl 2):S157-64. PubMed ID: 16958996
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for regional nodal relapse in breast cancer patients with one to three positive axillary nodes.
Yates L; Kirby A; Crichton S; Gillett C; Cane P; Fentiman I; Sawyer E
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2093-103. PubMed ID: 21530101
[TBL] [Abstract][Full Text] [Related]
24. Multicentric and multifocal versus unifocal breast cancer: is the tumor-node-metastasis classification justified?
Weissenbacher TM; Zschage M; Janni W; Jeschke U; Dimpfl T; Mayr D; Rack B; Schindlbeck C; Friese K; Dian D
Breast Cancer Res Treat; 2010 Jul; 122(1):27-34. PubMed ID: 20454925
[TBL] [Abstract][Full Text] [Related]
25. Lymph node ratio: a new feature for defining risk category of node-positive breast cancer patients.
Yang C; Liu F; Li S; Li W; Zhai L; Ren M; Li Y; Lang R; Fan Y; Zhang X; Fu L
Int J Surg Pathol; 2012 Dec; 20(6):546-54. PubMed ID: 22736300
[TBL] [Abstract][Full Text] [Related]
26. Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer.
Nakamura Y; Yasuoka H; Tsujimoto M; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
Breast Cancer Res Treat; 2005 May; 91(2):125-32. PubMed ID: 15868440
[TBL] [Abstract][Full Text] [Related]
27. Prognostic factors affecting survival and disease-free survival in lymph node-negative breast carcinomas.
Kuru B; Camlibel M; Gulcelik MA; Alagol H
J Surg Oncol; 2003 Jul; 83(3):167-72. PubMed ID: 12827686
[TBL] [Abstract][Full Text] [Related]
28. Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer.
Hatoum HA; Jamali FR; El-Saghir NS; Musallam KM; Seoud M; Dimassi H; Abbas J; Khalife M; Boulos FI; Tawil AN; Geara FB; Salem Z; Shamseddine AA; Al-Feghali K; Shamseddine AI
Ann Surg Oncol; 2009 Dec; 16(12):3388-95. PubMed ID: 19655200
[TBL] [Abstract][Full Text] [Related]
29. Impact of screening and risk factors for local recurrence and survival after conservative surgery and radiotherapy for early breast cancer: results from a large series with long-term follow-up.
Kunkler IH; Kerr GR; Thomas JS; Jack WJ; Bartlett JM; Pedersen HC; Cameron DA; Dixon JM; Chetty U;
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):829-38. PubMed ID: 22197227
[TBL] [Abstract][Full Text] [Related]
30. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
[TBL] [Abstract][Full Text] [Related]
31. Combined-modality treatment for isolated recurrences of breast carcinoma: update on 30 years of experience at the University of Texas M.D. Anderson Cancer Center and assessment of prognostic factors.
Hanrahan EO; Broglio KR; Buzdar AU; Theriault RL; Valero V; Cristofanilli M; Yin G; Kau SW; Hortobagyi GN; Rivera E
Cancer; 2005 Sep; 104(6):1158-71. PubMed ID: 16047352
[TBL] [Abstract][Full Text] [Related]
32. Prognostic factors for survival in breast cancer patients who developed distant metastasis subsequent to definitive surgery.
Kuru B; Camlibel M; Dinc S; Gulcelik MA; Gonullu D; Alagol H
Singapore Med J; 2008 Nov; 49(11):904-11. PubMed ID: 19037557
[TBL] [Abstract][Full Text] [Related]
33. Survival benefit of post-mastectomy radiotherapy in breast carcinoma patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis.
Duraker N; Demir D; Bati B; Yilmaz BD; Bati Y; Çaynak ZC; Sobutay E
Jpn J Clin Oncol; 2012 Jul; 42(7):601-8. PubMed ID: 22511807
[TBL] [Abstract][Full Text] [Related]
34. Comparison of Weibull and Lognormal Cure Models with Cox in the Survival Analysis Of Breast Cancer Patients in Rafsanjan.
Hoseini M; Bahrampour A; Mirzaee M
J Res Health Sci; 2017 Feb; 17(1):e00369. PubMed ID: 28413171
[TBL] [Abstract][Full Text] [Related]
35. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
[TBL] [Abstract][Full Text] [Related]
36. Increased risk of contralateral breast cancers among overweight and obese women: a time-dependent association.
Majed B; Dozol A; Ribassin-Majed L; Senouci K; Asselain B
Breast Cancer Res Treat; 2011 Apr; 126(3):729-38. PubMed ID: 20872242
[TBL] [Abstract][Full Text] [Related]
37. Prediction of the long-term survival in breast cancer patients according to the present oncological status.
Hatteville L; Mahe C; Hill C
Stat Med; 2002 Aug; 21(16):2345-54. PubMed ID: 12210619
[TBL] [Abstract][Full Text] [Related]
38. Fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus FAC followed by weekly paclitaxel as adjuvant therapy for high-risk, node-negative breast cancer: results from the GEICAM/2003-02 study.
Martín M; Ruiz A; Ruiz Borrego M; Barnadas A; González S; Calvo L; Margelí Vila M; Antón A; Rodríguez-Lescure A; Seguí-Palmer MA; Muñoz-Mateu M; Dorca Ribugent J; López-Vega JM; Jara C; Espinosa E; Mendiola Fernández C; Andrés R; Ribelles N; Plazaola A; Sánchez-Rovira P; Salvador Bofill J; Crespo C; Carabantes FJ; Servitja S; Chacón JI; Rodríguez CA; Hernando B; Álvarez I; Carrasco E; Lluch A
J Clin Oncol; 2013 Jul; 31(20):2593-9. PubMed ID: 23733779
[TBL] [Abstract][Full Text] [Related]
39. Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients: a competing risk analysis.
Wulaningsih W; Vahdaninia M; Rowley M; Holmberg L; Garmo H; Malmstrom H; Lambe M; Hammar N; Walldius G; Jungner I; Coolen AC; Van Hemelrijck M
BMC Cancer; 2015 Nov; 15():913. PubMed ID: 26577580
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors for longer disease free survival and overall survival after surgical resection of isolated liver metastasis from breast cancer.
Zegarac M; Nikolic S; Gavrilovic D; Jevric M; Kolarevic D; Nikolic-Tomasevic Z; Kocic M; Djurisic I; Inic Z; Ilic V; Santrac N
J BUON; 2013; 18(4):859-65. PubMed ID: 24344009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
